Basophil Activation Techniques: Staining of Exteriorized Granule Matrix.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 9 8 2020
pubmed: 9 8 2020
medline: 13 3 2021
Statut: ppublish

Résumé

The basis of traditional flow cytometry allergy diagnosis is measurement of the expression of basophilic surface activation and/or degranulation markers. Basophils, upon encounter with a specific allergen that cross-links surface FcRI-bound IgE antibodies, not only secrete and release quantifiable bioactive mediators but also upregulate the expression of different markers (e.g., CD63, CD203c) which can be detected by multicolor flow cytometry using specific monoclonal antibodies. Here, we describe a novel technique that relies upon the staining of exteriorized anionic proteoglycans from a basophil granule matrix by cationic fluorescent avidin probes.

Identifiants

pubmed: 32766978
doi: 10.1007/978-1-0716-0696-4_17
doi:

Substances chimiques

Biomarkers 0
Fluoresceins 0
Proteoglycans 0
fluorescein-avidin 0
Avidin 1405-69-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

213-218

Références

Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D (1991) Monitoring human basophil activation via CD63 monoclonal antobody-435. J Allergy Clin Immunol 88:328–338
doi: 10.1016/0091-6749(91)90094-5 pubmed: 1716273
Joulia R, Mailhol C, Valitutti S, Didier A, Espinosa E (2017) Direct monitoring of basophil degranulation by using avidin-based probes. J Allergy Clin Immunol 140:1159–1162
doi: 10.1016/j.jaci.2017.03.030 pubmed: 28433691
Mukai K, Chinthrajah RS, Nadeau KC, Tsai M, Gaudenzio N, Galli SJ (2017) A new fluorescent-avidin-based method for quantifying basophil activation in whole blood. J Allergy Clin Immunol 140:1202–1206
doi: 10.1016/j.jaci.2017.03.052 pubmed: 28606590 pmcid: 5632583

Auteurs

Jessy Elst (J)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium. jessy.elst@uantwerpen.be.

Vito Sabato (V)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.
Department of Immunology and Allergology, AZ Jan Palfijn Gent, Gent, Belgium.

Margo M Hagendorens (MM)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.
Faculty of Medicine and Health Science, Department of Pediatrics, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.

Michel van Houdt (M)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.

Margaretha A Faber (MA)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.

Chris H Bridts (CH)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.

Didier G Ebo (DG)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.
Department of Immunology and Allergology, AZ Jan Palfijn Gent, Gent, Belgium.

Christel Mertens (C)

Faculty of Medicine and Health Science, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH